NXLNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Nexalin Technology, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$2.36+0.01 (+0.43%)
Close on Oct 19, 2026
- Market cap
- $49.90M
- P/E (TTM)
- –
- Dividend yield
- –
Nexalin Technology, Inc. revenue by segment
By business segment
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|
| Device Sales [Member] | $136.00K | $55.50K | – | $1.16M | $25.00K | 45.1% | +145.0% |
| Equipment [Member] | $89.04K | $37.83K | $27.30K | $26.78K | $15.22K | 29.5% | +135.4% |
| Licensing Fee [Member] | $49.11K | $69.50K | $82.08K | $79.19K | $102.91K | 16.3% | -29.3% |
| Other [Member] | $27.49K | $5.89K | $1.37K | $26.41K | $937 | 9.1% | +366.4% |
| Royalty Fee [Member] | – | – | – | $24.48K | – | – | – |
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|
| China | $190.30K | $85.25K | $3.61K | $1.21M | $26.13K | 63.1% | +123.2% |
| International [Member] | $190.30K | $85.25K | – | – | – | 63.1% | +123.2% |
| United States | $111.35K | $83.47K | $107.13K | $113.54K | $117.93K | 36.9% | +33.4% |
From the segment and revenue-disaggregation notes of Nexalin Technology's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.